| L P Britt Pa | |
|
2270 W Main St Ste A, Tupelo, MS 38801-3144 | |
| (662) 844-3436 | |
| Not Available |
| Full Name | L P Britt Pa |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 2270 W Main St Ste A, Tupelo, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285820894 | NPI | - | NPPES |
| 08651 | Other | MS | SPECTERA |
| P00027863 | Other | MS | RAILROAD MEDICARE |
| 09016224 | Medicaid | MS | |
| 47792 | Other | MS | DAVIS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 510 (Mississippi) | Primary |
| Provider Name | Lloyd Perry Britt |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1992822985 PECOS PAC ID: 4688759962 Enrollment ID: I20080311000470 |
News Archive
Brahim Chaqour, PhD, professor of cell biology and ophthalmology at SUNY Downstate Medical Center, has received two awards to support research into treatment of currently incurable vision-threatening diseases. The new awards, totaling $2,008,973, are from the National Eye Institute of the National Institutes of Health.
University of Queensland researchers have identified a protein that is crucially involved in how our memories are stored and processed, paving the way for new strategies to treat conditions certain mental disorders.
De-risking represents a relatively new but developing strategy designed to quickly assess if a new drug has a liability. Knowing your compound's risk for drug-to-drug interactions (DDI), drug induced liver injury (DILI) and metabolites in safety testing (MIST) early on in drug development, leads to greater confidence and added value on your molecule's journey to market.
Elios Therapeutics, LLC recently received FDA approval of its Investigational New Drug (IND) application and its randomized phase IIb trial planned to enroll 120 stage III and IV (resected) melanoma patients to assess the ability of a personalized vaccine to prevent recurrence.
Scientists have wrestled to understand why Huntington's disease, which is caused by a single gene mutation, can produce such variable symptoms. An authoritative review by a group of leading experts summarizes the progress relating cell loss in the striatum and cerebral cortex to symptom profile in Huntington's disease, suggesting a possible direction for developing targeted therapies.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| L P Britt Pa 2270 W Main St Ste A, Tupelo, MS 38801-3144 Ph: (662) 844-3436 | L P Britt Pa 2270 W Main St Ste A, Tupelo, MS 38801-3144 Ph: (662) 844-3436 |
News Archive
Brahim Chaqour, PhD, professor of cell biology and ophthalmology at SUNY Downstate Medical Center, has received two awards to support research into treatment of currently incurable vision-threatening diseases. The new awards, totaling $2,008,973, are from the National Eye Institute of the National Institutes of Health.
University of Queensland researchers have identified a protein that is crucially involved in how our memories are stored and processed, paving the way for new strategies to treat conditions certain mental disorders.
De-risking represents a relatively new but developing strategy designed to quickly assess if a new drug has a liability. Knowing your compound's risk for drug-to-drug interactions (DDI), drug induced liver injury (DILI) and metabolites in safety testing (MIST) early on in drug development, leads to greater confidence and added value on your molecule's journey to market.
Elios Therapeutics, LLC recently received FDA approval of its Investigational New Drug (IND) application and its randomized phase IIb trial planned to enroll 120 stage III and IV (resected) melanoma patients to assess the ability of a personalized vaccine to prevent recurrence.
Scientists have wrestled to understand why Huntington's disease, which is caused by a single gene mutation, can produce such variable symptoms. An authoritative review by a group of leading experts summarizes the progress relating cell loss in the striatum and cerebral cortex to symptom profile in Huntington's disease, suggesting a possible direction for developing targeted therapies.
› Verified 8 days ago
Vision Care, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 3437 Tupelo Commons, Suite 101, Tupelo, MS 38804 Phone: 662-842-2000 Fax: 662-842-0379 | |
Dr. Steve Beaty, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 837 Kings Crossing Dr Ste 10, Tupelo, MS 38804 Phone: 662-269-4175 Fax: 662-269-4176 | |
Dr. Joe Chaddrick Kea, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3437 Tupelo Commons, Suite 101, Tupelo, MS 38804 Phone: 662-842-2000 Fax: 662-842-0379 | |
Dr. Allison Burks Norwood, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 837 Kings Crossing Dr Ste 10, Tupelo, MS 38804 Phone: 662-842-3037 Fax: 662-842-3869 | |
Wedo Eyes Llc Optometrist Medicare: Medicare Enrolled Practice Location: 3833 N Gloster St, Tupelo, MS 38804 Phone: 662-269-0856 Fax: 662-269-0856 | |
Dr. William M Dickerson Jr., OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 322 West Main, Tupelo, MS 38802 Phone: 662-842-6634 Fax: 662-842-6626 | |
Joshua Hunter Wilson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3833 N Gloster St, Tupelo, MS 38804 Phone: 662-269-0856 Fax: 662-269-0856 |